Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ruxianning Patch is a transdermal topical preparation primarily composed of sulfate mineral powder and excipients. It is indicated for the treatment of mastitis and mammary gland hyperplasia. The patch functions by creating a hypertonic environment on the skin, which facilitates the absorption of fluid and milk from breast tissue. This action helps to unblock mammary ducts, accelerate local lymphatic and blood circulation, and enhance the phagocytic function of reticuloendothelial cells, thereby alleviating symptoms such as breast lumps, swelling, and pain. It is considered a traditional Chinese medicine device for treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ruxianning Patch.